Articles Vol. 65 No. 6 30/10/2024

5. TELEHEALTH INTERVENTION IN OUTPATIENT TREATMENT MANAGEMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AT LIEN CHIEU DISTRICT MEDICAL CENTER, DA NANG CITY: A SWOT ANALYSIS

Dat Truong Van1, Trang Vo Pham Mi2, Hoang Thai Minh3, Nhieu Bui Van4, Trung Tran Dinh5, Luyen Pham Dinh3, Anh Le Thi Kim1
1 Hanoi University of Public Health
2 Lien Chieu District Medical Center, Da Nang City
3 University of Medicine and Pharmacy at Ho Chi Minh City
4 Center for Health Science Training and Research, Danang City
5 Danang University of Medical Technology and Pharmacy
Corresponding author: phd2051001@studenthuph.edu.vn
DOI: 10.52163/yhc.v65i6.1563
99 Views
48 Downloads
Abstract

Objective: This study aimed to evaluate the strengths, weaknesses, opportunities, and threats (SWOT) of implementing telehealth intervention in the management of outpatients with type 2 diabetes at Lien Chieu District Medical Center, Da Nang City.

Methods: A cross-sectional study was conducted in October 2023 at Lien Chieu District Medical Center. The study included 33 outpatients with type 2 diabetes and 13 healthcare workers working in Department of Internal Medicine and the Department of Public Health and Food Safety.

Results: The average age of the study subjects was 46.7 ± 14.2 years, with healthcare workers being younger at 31.1 ± 8.2 years and females comprising the majority (63.0%). Based on a 5-point Likert scale, the patients and healthcare workers rated the strengths, weaknesses, opportunities, and threats at 76.1%, 69.6%, 52.2%, 56.5%.

Conlusion: Lien Chieu District Medical Center has more strengths and opportunities than weaknesses, with strong agreement from both patients and healthcare workers, regarding the implementing telehealth intervention in the management of outpatients with type 2 diabetes. Therefore, it is feasible to implement telehealth intervention for patients with type 2 diabetes at Lien Chieu center.

Keywords
type 2 diabetes outpatients SWOT telehealth
References
[1]
Catalyst, NEJM. What is telehealth? NEJM Catalyst. 2018;4 (1). Google Scholar
[2]
Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, et al. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study). Diabetes care. Google Scholar
[3]
;34 (3):533-9. Google Scholar
[4]
Cohen LB, Taveira TH, Wu WC, Pirraglia PA. Pharmacist-led telehealth disease management program for patients with diabetes and depression. Journal of telemedicine and telecare. 2020;26 (5):294-302. Google Scholar
[5]
Wong VW, Wang A, Manoharan M. Utilisation of telehealth for outpatient diabetes management during COVID-19 pandemic: how did the patients fare? Internal medicine journal. 2021;51(12):2021-6. Google Scholar
[6]
Kwak SG, Kim JH. Central limit theorem: the cornerstone of modern statistics. Korean journal of anesthesiology. 2017;70 (2):144-56. Google Scholar
[7]
Mechanic OJ, Persaud Y, Kimball AB. Telehealth Systems. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Yudy Persaud declares no relevant financial relationships with ineligible companies. Disclosure: Alexa Kimball declares no relevant financial relationships with ineligible companies.: StatPearls Publishing. Copyright © 2024, StatPearls Publishing LLC.; Google Scholar
[8]
Murphy M, Scott LJ, Salisbury C, Turner A, Scott A, Denholm R, et al. Implementation of remote consulting in UK primary care following the COVID-19 pandemic: A mixed-methods longitudinal study. The British journal of general practice : the journal of the Royal College of General Practitioners. 2021;71 (704):e166-e77. Google Scholar
[9]
Crossen SS, Bruggeman BS, Haller MJ, Raymond JK. Challenges and Opportunities in Using Telehealth for Diabetes Care. Diabetes spectrum : A publication of the American Diabetes Association. 2022;35 (1):33-42. Google Scholar